Document is current
Any future updates will be listed below
-
Authors
Vogt, Kristian https://orcid.org/0009-0001-0137-4464
Krämer, Stefan https://orcid.org/0009-0004-9485-0969
Schreibing, Teresa Maria https://orcid.org/0000-0003-0593-5123
Busch, Martin https://orcid.org/0000-0002-7889-6156
Schmitt, Tobias
Mosberger, Sebastian https://orcid.org/0009-0001-1152-9925
Schumbrink, Fabian
Neumann, Thomas https://orcid.org/0000-0003-3755-9038
Bergner, Raoul https://orcid.org/0000-0002-7965-1273
Rauen, Thomas https://orcid.org/0000-0002-6544-8901
-
Funding
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 18 November 2025
First Online: 2 December 2025
Declarations
:
: S. Krämer, K. Vogt, T. Schreibing, T. Schmitt, S. Mosberger, F. Schumbrink: no disclosures. T. Rauen, M. Busch, R. Bergner, T. Neumann: received consultancy honoraria from Vifor Pharma.
: This retrospective analysis was approved by the involved local ethic committees (Aachen: EK 164/19, approved on 05–30-2019; St. Gallen: 2020–01350, approved on 04–07-2021; Jena: 2020–1837-Daten, approved on 06–26-2020; Ludwigshafen: 2020–14843-Retrospective, approved on 02–10-2020). The study was conducted in accordance with the ethical standards of the Declaration of Helsinki (December 2024 version).
